|
ATE212378T1
(de)
|
1993-06-04 |
2002-02-15 |
Whitehead Biomedical Inst |
Stressproteine und ihre verwendung
|
|
US5997873A
(en)
*
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
*
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
AU724399B2
(en)
|
1995-08-18 |
2000-09-21 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US6130087A
(en)
*
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
JP4484969B2
(ja)
*
|
1996-11-26 |
2010-06-16 |
ヌベンタ バイオファーマスティカル コーポレイション |
ストレスタンパク質を含む組成物を使用する免疫応答
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
*
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
EP1047451A1
(en)
*
|
1997-02-18 |
2000-11-02 |
Whitehead Institute For Biomedical Research |
Use of heat shock proteins to deliver moieties into cells
|
|
US6709672B2
(en)
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
BE1011033A6
(fr)
*
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
ATE231917T1
(de)
*
|
1997-08-05 |
2003-02-15 |
Stressgen Biotechnologies Corp |
Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine
|
|
AU779770B2
(en)
*
|
1997-08-05 |
2005-02-10 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU761432B2
(en)
*
|
1997-10-31 |
2003-06-05 |
Sloan-Kettering Institute For Cancer Research |
Conjugate heat shock protein-binding peptides
|
|
AU1045199A
(en)
*
|
1997-11-05 |
1999-05-24 |
Isis Innovation Limited |
Cancer gene
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
ES2439014T3
(es)
|
1998-02-20 |
2014-01-21 |
The University Of Miami |
Complejo de péptido antigénico-proteína de choque térmico modificada
|
|
WO1999064583A2
(en)
*
|
1998-06-12 |
1999-12-16 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Healt H And Human Services |
Compositions and methods for modulating proteolytic degradation of intracellular targets
|
|
US6160088A
(en)
*
|
1998-07-29 |
2000-12-12 |
Sloan-Kettering Institute For Cancer |
KDEL receptor inhibitors
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6497880B1
(en)
|
1998-12-08 |
2002-12-24 |
Stressgen Biotechnologies Corporation |
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
|
|
EP1196772A2
(en)
|
1999-07-08 |
2002-04-17 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
WO2001023421A2
(en)
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
AU1814101A
(en)
|
2000-01-14 |
2001-07-24 |
Massachusetts Institute Of Technology |
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete ATP binding domain and is CD4+ cell-independent
|
|
ATE375169T1
(de)
*
|
2000-04-14 |
2007-10-15 |
Intercell Ag |
Modifizierte peptide enthaltende pharmazeutische präparationen
|
|
EP1284986A4
(en)
*
|
2000-04-17 |
2005-08-24 |
James E Rothman |
COMPLEXIZING PROTEIN ANTIGENES AND HEAT SHOCK PROTEINS BY JAVELIN
|
|
AU6669401A
(en)
|
2000-06-02 |
2001-12-11 |
Univ Connecticut Health Ct |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
IL153474A0
(en)
|
2000-06-26 |
2003-07-06 |
Stressgen Biotechnologies Corp |
Human papilloma virus treatment
|
|
EP1363938B1
(en)
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
NZ521694A
(en)
|
2002-09-30 |
2005-05-27 |
Co2 Pac Ltd |
Container structure for removal of vacuum pressure
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
WO2002062959A2
(en)
|
2001-02-05 |
2002-08-15 |
Stressgen Biotechnologies Corp. |
Hepatitis b virus treatment
|
|
GB0106161D0
(en)
*
|
2001-03-13 |
2001-05-02 |
King S College London |
Immunomodulators
|
|
US20040043419A1
(en)
*
|
2001-04-17 |
2004-03-04 |
Rothman James E. |
Javelinization of protein antigens to heat shock proteins
|
|
PL375043A1
(en)
|
2001-08-20 |
2005-11-14 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin, useful for the treatment of cancer and infectious disease
|
|
CN1304559C
(zh)
*
|
2001-10-09 |
2007-03-14 |
杭州康科生物技术有限公司 |
表达热休克蛋白的溶瘤微生物及其应用
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
ATE408838T1
(de)
*
|
2003-01-03 |
2008-10-15 |
Aurelium Biopharma Inc |
Auf hsc70 gerichtete diagnostika und therapeutika für eine gegen mehrere arzneistoffe resistente tumorerkrankung
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
GB0303507D0
(en)
*
|
2003-02-14 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
MXPA05010881A
(es)
*
|
2003-04-11 |
2006-05-31 |
Antigenics Inc |
Vacunas e inmunoterapias a base de proteina de choque termico mejorada.
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004096859A1
(ja)
*
|
2003-04-28 |
2004-11-11 |
Sekisui Chemical Co., Ltd. |
シャペロニン－目的タンパク質複合体及びその生産方法、目的タンパク質の安定化方法、目的タンパク質の固定化方法、目的タンパク質の構造解析方法、徐放性製剤、並びに目的タンパク質に対する抗体の製造方法
|
|
WO2004098526A2
(en)
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
ES2396231T3
(es)
|
2003-05-21 |
2013-02-20 |
Biotech Tools S.A. |
Complejo peptídico
|
|
EP1479689A1
(en)
*
|
2003-05-21 |
2004-11-24 |
Biotech Tools S.A. |
Peptide complex
|
|
EP1625148B1
(en)
*
|
2003-05-21 |
2012-09-26 |
Biotech Tools S.A. |
Peptide complex
|
|
EP2289547B1
(en)
|
2003-09-12 |
2015-12-16 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
ATE493432T1
(de)
*
|
2003-11-12 |
2011-01-15 |
Alfa Biogene Internat B V |
Gewinnung von hitzeschockproteinen
|
|
WO2005065418A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
US7449196B2
(en)
*
|
2004-07-09 |
2008-11-11 |
Robert Sabin |
Anti tumor compositions and methods of use
|
|
US20060120995A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Shah Maulik R |
Neoadjuvant genetic compositions and methods
|
|
WO2006073970A2
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2007050978A2
(en)
*
|
2005-10-29 |
2007-05-03 |
University Of Connecticut |
Methods for the elimination of pathogens and other particulate agents
|
|
EP2007427A4
(en)
|
2006-04-11 |
2012-04-04 |
Yeda Res & Dev |
IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS
|
|
US20080081051A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Robert Sabin |
Method of manufacturing anti-tumor and anti-viral compositions
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
WO2008124483A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
EP2257301B1
(en)
|
2008-03-03 |
2014-01-22 |
The University of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
ES2651924T3
(es)
|
2008-04-18 |
2018-01-30 |
The General Hospital Corporation |
Inmunoterapias que emplean vacunas autoensamblantes
|
|
WO2010060026A1
(en)
*
|
2008-11-21 |
2010-05-27 |
University Of Miami |
Hiv/siv vaccines for the generation of mucosal and systemic immunity
|
|
EP2270124A1
(en)
*
|
2009-06-30 |
2011-01-05 |
The Procter & Gamble Company |
Bleaching compositions comprising a perfume delivery system
|
|
WO2014093950A1
(en)
|
2012-12-14 |
2014-06-19 |
Virginia Commonwealth University |
Immune modulator for immunotherapy and vaccine formulation
|
|
FR3011850B1
(fr)
*
|
2013-10-15 |
2018-04-06 |
Cfl Biotech |
Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
|
|
KR20170109582A
(ko)
|
2015-02-06 |
2017-09-29 |
히트 바이오로직스, 인코퍼레이티드 |
벡터 공동 발현 백신 및 공동 자극 분자
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
CA3017356A1
(en)
|
2016-03-10 |
2017-09-14 |
Aperisys, Inc. |
Antigen-binding fusion proteins with modified hsp70 domains
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
US11548930B2
(en)
|
2017-04-04 |
2023-01-10 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
KR20210005646A
(ko)
|
2018-04-26 |
2021-01-14 |
아게누스 인코포레이티드 |
열쇼크 단백질-결합 펩티드 조성물 및 그의 이용 방법
|
|
US20220218814A1
(en)
*
|
2019-05-10 |
2022-07-14 |
Academia Sinica |
A vaccine comprising a nanoparticle encapsulating epitopes and adjuvant for neutralizing virus infection
|
|
WO2022047248A1
(en)
*
|
2020-08-28 |
2022-03-03 |
Torigen Pharmaceuticals, Inc. |
Immune memory enhanced preparations and uses thereof
|